Lansoprazole Arrow

Lansoprazole, the active ingredient in Lansoprazole Arrow, is a proton pump inhibitor presented as an oral dosage form for systemic use. It reduces gastric acid production and is used to treat conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, and related acid‑related disorders in adult patients.

GNH USA supplies Lansoprazole Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required.

Lansoprazole is a proton pump inhibitor indicated for several acid‑related gastrointestinal conditions.

- Gastro‑esophageal reflux disease (GERD): relieves heartburn and promotes healing of esophageal erosion. - Peptic ulcer disease: accelerates ulcer healing and reduces recurrence. - Helicobacter pylori eradication: used as part of combination therapy to eliminate H. pylori infection. - Erosive esophagitis: speeds mucosal healing and prevents relapse. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion in this rare endocrine disorder.

Lansoprazole may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate pain may occur. - Diarrhea: loose stools are reported. - Abdominal pain: discomfort in the stomach area. - Nausea: feeling of sickness.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis may develop. - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat.

Before prescribing Lansoprazole, clinicians should consider several safety aspects.

- Assess renal function: dose adjustment may be needed in severe impairment. - Monitor for infection: prolonged use can increase risk of gastrointestinal infections. - Use cautiously in elderly: higher incidence of fractures reported. - Avoid abrupt discontinuation: may cause rebound acid hypersecretion. - Consider drug interactions: review concomitant medications for potential effects. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Lansoprazole can affect the pharmacokinetics of several medicines, requiring attention to interaction risk.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activation. - Atazanavir: decreased absorption and antiviral efficacy. - Methotrexate (high dose): increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Warfarin: variable INR, monitor coagulation. - Diazepam: increased plasma levels, watch for sedation. - Digoxin: altered absorption, check serum concentrations.